Organogenesis Holdings Inc.
ORGO
$4.69
-$0.1911-3.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -82.59% | -156.77% | -264.66% | -56.86% | -68.16% |
| Total Depreciation and Amortization | 10.80% | -20.78% | -19.59% | -20.49% | -14.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.64% | 138.87% | 101.09% | 23.64% | 13.01% |
| Change in Net Operating Assets | -170.51% | -67.64% | 27.15% | 32.65% | 46.97% |
| Cash from Operations | -54.04% | -50.59% | 30.33% | 40.61% | 24.37% |
| Capital Expenditure | 58.82% | 68.47% | 62.89% | 45.31% | 28.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 58.82% | 68.47% | 62.89% | 45.31% | 28.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,207.64% | -29.05% | -71.04% | -74.49% | -71.69% |
| Issuance of Common Stock | 124,700.00% | -- | 546.43% | -89.83% | -99.95% |
| Repurchase of Common Stock | -7,904.50% | -252.55% | -251.80% | -152.18% | 48.61% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 602.03% | -39.01% | -82.41% | -157.57% | -150.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,935.59% | 57.60% | 104.13% | 99.64% | 109.33% |